09/05/2014 - 20:00
WASHINGTON – Treating acute venous thromboembolism with the fixed-dose oral factor Xa inhibitor apixaban significantly reduces subsequent all-cause hospitalizations, compared with conventional...
Field of Interest: Cardiology
Categories:
News Feed: Internal Medicine News - Cardiology